Insider Transactions in Q2 2021 at My Md Pharmaceuticals, Inc. (MYMD)

Date	Insider	Transaction	Ownership Type	Shares Traded	Value / Price
Apr 16 2021	Christopher C Chapman Jr President, Chief Med. Officer	BUY Grant, award, or other acquisition	Direct	96,475 +50.0%	-
Apr 16 2021	Christopher C Schreiber Director	SELL Payment of exercise price or tax liability	Direct	46,113 -34.32%	$184,452 $4.94 P/Share
Apr 16 2021	Christopher C Schreiber Director	BUY Exercise of conversion of derivative security	Direct	131,750 +49.51%	-
Apr 16 2021	Billy Joe White Director	SELL Payment of exercise price or tax liability	Direct	38,325 -35.0%	$153,300 $4.94 P/Share
Apr 16 2021	Billy Joe White Director	BUY Exercise of conversion of derivative security	Direct	109,500 +49.41%	-
Apr 16 2021	Joshua Silverman Director	SELL Payment of exercise price or tax liability	Direct	38,325 -35.0%	$153,300 $4.94 P/Share
Apr 16 2021	Joshua Silverman Director	BUY Exercise of conversion of derivative security	Direct	109,500 +49.41%	-
Apr 16 2021	Robert C Schroeder Director	SELL Payment of exercise price or tax liability	Direct	14,694 -33.45%	$58,776 $4.94 P/Share
Apr 16 2021	Robert C Schroeder Director	BUY Exercise of conversion of derivative security	Direct	43,930 +50.0%	-

Receive a notification when an Institution or Guru buys or sells MYMD shares.

Notify only if

Value

Get notified when an My Md Pharmaceuticals, Inc. insider buys or sells MYMD shares.

Notify only if

Operation

Value

Type

Receive news related to MyMD Pharmaceuticals, Inc.